Last kr107.10 SEK
Change Today -0.30 / -0.28%
Volume 92.4K
As of 6:38 AM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

meda ab-a shs (MEDAA) Snapshot

Open
kr107.70
Previous Close
kr107.40
Day High
kr107.70
Day Low
kr106.90
52 Week High
04/25/14 - kr129.90
52 Week Low
11/7/13 - kr69.70
Market Cap
32.4B
Average Volume 10 Days
438.8K
EPS TTM
kr2.83
Shares Outstanding
302.2M
EX-Date
05/8/14
P/E TM
37.8x
Dividend
kr2.50
Dividend Yield
2.33%
Current Stock Chart for MEDA AB-A SHS (MEDAA)

Related News

No related news articles were found.

meda ab-a shs (MEDAA) Related Businessweek News

No Related Businessweek News Found

meda ab-a shs (MEDAA) Details

Meda AB operates as a specialty pharmaceutical company worldwide. It manufactures and sells specialty pharmaceutical products, branded generics, over-the-counter drugs, and other products in various therapy areas, such as respiratory, dermatology, gastroenterology, cardiology, pain and inflammation, and CNS, as well as metabolism/vitamins. The company markets and sells its products through distributors in approximately 120 countries. Meda AB is headquartered in Solna, Sweden.

2,925 Employees
Last Reported Date: 04/2/14

meda ab-a shs (MEDAA) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: kr2.1M
Compensation as of Fiscal Year 2013.

meda ab-a shs (MEDAA) Key Developments

Meda AB Approves Dividend for the Fiscal Year 2013

Meda AB at its annual general meeting held on May 7, 2014, declared a dividend of SEK 2.50 per share for the fiscal year 2013.

Meda AB Reports Group and Parent Earnings Results for the First Quarter Ended March 31, 2014; Reaffirms Earnings Guidance for the Full Year 2014

Meda AB reported group and parent earnings results for the first quarter ended March 31, 2014. For the quarter, the group's net sales reached SEK 3,365 million compared with SEK 3,199 million a year ago, corresponding to organic growth of 3% compared to the previous year. EBITDA was SEK 1,010 million compared with SEK 923 million a year ago, yielding a 30.0% margin. Operating profit totaled SEK 462 million compared with SEK 384 million a year ago. Profit after tax was amounted to SEK 260 million compared with SEK 208 million a year ago. Earnings per share reached SEK 0.86 compared with SEK 0.70 a year ago. Cash earnings per share amounted to SEK 1.97 compared with SEK 1.77 a year ago. Return on equity, rolling 12 months was 6.6% compared to 6.9% for the last year. Cash flow from operating activities was SEK 615 million compared to SEK 551 million and free cash flow was SEK 595 million compared to SEK 536 million for the last year. For the quarter, the parent company reported net sales of SEK 1,416 million compared to SEK 1,297 million, operating profit (EBIT) of SEK 165 million compared to SEK 120 million, profit for the period after net financial items (EBT) of SEK 156 million compared to SEK 147 million, met profit of SEK 11 million compared to SEK 9 million for the last year. The company announced that it remain committed to previously announced objectives for the full year 2014 on continued healthy organic growth at the same level as 2013, and an improved EBITDA margin.

Meda Considers Acquisitions

Meda AB (OM:MEDA A) to consider acquisitions. Jörg-Thomas, Chief Executive Officer of Meda said. "Intensifying our focus on acquisitions will be even more important if the company is to achieve its goals. Meda has both financial and organizational capacity for growth through major acquisitions as well as a good track-record. I look forward to taking Meda to the next level, together with my colleagues."

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MEDAA:SS kr107.10 SEK -0.30

MEDAA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actelion Ltd SFr.108.90 CHF -0.40
Almirall SA €10.72 EUR +0.11
Ipsen SA €33.06 EUR +0.135
Orion OYJ €26.51 EUR -0.32
Recordati SpA €11.93 EUR -0.12
View Industry Companies
 

Industry Analysis

MEDAA

Industry Average

Valuation MEDAA Industry Range
Price/Earnings 36.1x
Price/Sales 2.3x
Price/Book 2.0x
Price/Cash Flow 36.1x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDA AB-A SHS, please visit www.meda.se. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.